BIOGEN (DENMARK) A/S: Financial statements 2024
CVR: 21682977
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
BIOGEN (DENMARK) A/S (CVR 21682977) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 234,002,651 and a net result of DKK 7,526,703 compared with DKK 8,338,739 the year before. That is a decrease of 9.8% compared with the year before. The profit margin was 3.2%. Equity in the 2024 report amounted to DKK 146,322,445. The solvency ratio was 76.6%. The company had 22 employees in the financial year.
- Revenue
- DKK 234,002,651
- Gross Profit
- DKK 32,876,696
- Profit/Loss
- DKK 7,526,703
- Equity
- DKK 146,322,445
- Total Assets
- DKK 191,111,566
- Employees
- 22
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 234 mio. | 32.9 mio. | 7.5 mio. | 146.3 mio. | 22 |
| 2023 | 259.6 mio. | 44.2 mio. | 8.3 mio. | 138.8 mio. | 24 |
| 2022 | 307.5 mio. | 47 mio. | 8.4 mio. | 130.5 mio. | 24 |
| 2021 | 259.7 mio. | 45.9 mio. | 7.6 mio. | 122 mio. | 22 |
| 2020 | 303.4 mio. | 51.7 mio. | 10.1 mio. | 114.5 mio. | 25 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
BIOGEN (DENMARK) A/S has won the tender "Amgros 2025 1.351.b" issued by Amgros I/S worth 22,702,680,000 DKK.
BIOGEN (DENMARK) A/S has won the tender "Amgros 2025 1.130.b" issued by Amgros I/S worth 630,000,000 DKK.
BIOGEN (DENMARK) A/S has won the tender "Amgros 2025 1.132.b" issued by Amgros I/S worth 188,000,000 DKK.
BIOGEN (DENMARK) A/S has published its annual report for 2023. Revenue came to DKK 259,564,233, and the net result was DKK 8,338,739.
BIOGEN (DENMARK) A/S has won the tender "Amgros 2024 1.351.b" issued by Amgros I/S worth 19,644,800,000 DKK.
About BIOGEN (DENMARK) A/S
BIOGEN (DENMARK) A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 1999. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named BIOGEN IDEC (DENMARK) A/S. The management consists of Erik Magnus Bodin. The board consists of Neil Raymond Sisak (chair), Allan Frank Fischer Petersen, Erik Magnus Bodin and Sergio Ferreira da Silva Teixeira. The company is owned by Biogen Netherlands B.V.. The company has 13 employees (2026). In 2025, the company reported revenue of DKK 178,728,185 and a net result of DKK 5,563,672 compared with DKK 7,526,703 the year before. Equity in the 2025 report amounted to DKK 151,886,117.